Free Trial

Tandem Diabetes Care (TNDM) Competitors

Tandem Diabetes Care logo
$12.27 -0.52 (-4.07%)
Closing price 04:00 PM Eastern
Extended Trading
$12.38 +0.11 (+0.93%)
As of 05:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TNDM vs. LIVN, WRBY, INSP, LQDA, LMAT, PRCT, AORT, EYE, ENOV, and CNMD

Should you be buying Tandem Diabetes Care stock or one of its competitors? The main competitors of Tandem Diabetes Care include LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), Liquidia Technologies (LQDA), LeMaitre Vascular (LMAT), PROCEPT BioRobotics (PRCT), Artivion (AORT), National Vision (EYE), Enovis (ENOV), and CONMED (CNMD). These companies are all part of the "medical equipment" industry.

Tandem Diabetes Care vs. Its Competitors

Tandem Diabetes Care (NASDAQ:TNDM) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk.

LivaNova has a net margin of -16.13% compared to Tandem Diabetes Care's net margin of -20.51%. LivaNova's return on equity of 14.57% beat Tandem Diabetes Care's return on equity.

Company Net Margins Return on Equity Return on Assets
Tandem Diabetes Care-20.51% -65.40% -13.87%
LivaNova -16.13%14.57%6.91%

In the previous week, Tandem Diabetes Care had 7 more articles in the media than LivaNova. MarketBeat recorded 20 mentions for Tandem Diabetes Care and 13 mentions for LivaNova. Tandem Diabetes Care's average media sentiment score of 1.44 beat LivaNova's score of 1.26 indicating that Tandem Diabetes Care is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tandem Diabetes Care
15 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
9 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tandem Diabetes Care presently has a consensus price target of $22.44, indicating a potential upside of 82.86%. LivaNova has a consensus price target of $59.71, indicating a potential upside of 6.22%. Given Tandem Diabetes Care's higher probable upside, research analysts clearly believe Tandem Diabetes Care is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tandem Diabetes Care
0 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.31
LivaNova
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.00

Tandem Diabetes Care has a beta of 1.45, meaning that its stock price is 45% more volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500.

97.6% of LivaNova shares are held by institutional investors. 1.9% of Tandem Diabetes Care shares are held by insiders. Comparatively, 0.3% of LivaNova shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

LivaNova has higher revenue and earnings than Tandem Diabetes Care. LivaNova is trading at a lower price-to-earnings ratio than Tandem Diabetes Care, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tandem Diabetes Care$940.20M0.88-$96.03M-$3.09-3.97
LivaNova$1.25B2.45$63.23M-$3.89-14.45

Summary

LivaNova beats Tandem Diabetes Care on 10 of the 17 factors compared between the two stocks.

Get Tandem Diabetes Care News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TNDM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TNDM vs. The Competition

MetricTandem Diabetes CareMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$829.08M$6.79B$5.79B$10.15B
Dividend YieldN/A1.23%5.69%4.60%
P/E Ratio-3.9725.5274.5925.92
Price / Sales0.8862.89453.5485.33
Price / CashN/A21.6337.0859.91
Price / Book3.065.0012.156.29
Net Income-$96.03M$176.38M$3.28B$270.77M
7 Day Performance-2.46%1.00%0.99%3.36%
1 Month Performance10.54%3.19%7.21%6.41%
1 Year Performance-71.96%12.30%63.07%28.24%

Tandem Diabetes Care Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TNDM
Tandem Diabetes Care
4.4852 of 5 stars
$12.27
-4.1%
$22.44
+82.9%
-70.1%$829.08M$940.20M-3.972,650Positive News
LIVN
LivaNova
2.8931 of 5 stars
$58.32
+0.6%
$59.71
+2.4%
+20.8%$3.18B$1.25B-14.992,900Positive News
WRBY
Warby Parker
1.6999 of 5 stars
$26.74
+2.8%
$24.06
-10.0%
+96.3%$2.81B$771.32M-382.003,780Positive News
Insider Trade
INSP
Inspire Medical Systems
4.9024 of 5 stars
$83.51
-3.4%
$164.50
+97.0%
-60.0%$2.47B$802.80M48.271,246Positive News
LQDA
Liquidia Technologies
3.7953 of 5 stars
$27.98
-3.0%
$32.11
+14.8%
+166.0%$2.41B$14M-16.4650Positive News
LMAT
LeMaitre Vascular
3.0999 of 5 stars
$97.07
-0.4%
$97.60
+0.5%
+8.6%$2.20B$219.86M47.12490Positive News
PRCT
PROCEPT BioRobotics
3.2385 of 5 stars
$38.92
-4.3%
$73.22
+88.1%
-50.5%$2.17B$274.95M-25.11430Positive News
AORT
Artivion
2.7348 of 5 stars
$43.34
-0.3%
$40.63
-6.2%
+73.7%$2.04B$388.54M-103.191,600Positive News
EYE
National Vision
2.7983 of 5 stars
$23.08
-1.7%
$24.73
+7.1%
+126.7%$1.83B$1.82B-128.2213,411Positive News
ENOV
Enovis
4.0637 of 5 stars
$31.39
-2.3%
$51.00
+62.5%
-26.7%$1.79B$2.11B-2.207,367Positive News
Insider Trade
Gap Up
CNMD
CONMED
4.1117 of 5 stars
$53.78
-2.2%
$59.80
+11.2%
-26.4%$1.66B$1.31B15.233,900

Related Companies and Tools


This page (NASDAQ:TNDM) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners